• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Vaccine for Hiv Using Novel Muscosal Vector and Adjuvant

Grant number: OPP1008294 | Funding period: 2009 - 2011

Completed

Related publications (3)

Scholarly works icon

Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: Efficacy and evolution of cytotoxic T lymphocyte escape in macaques

JC Reece, S Alcantara, S Gooneratne, S Jegaskanda, T Amaresena, CS Fernandez, K Laurie, A Hurt, SL O'Connor, M Harris, J Petravic, A Martyushev, A Grimm, MP Davenport, J Stambas, R De Rose, SJ Kent

2013-04-01

There is an urgent need for a human immunodeficiency virus (HIV) vaccine that induces robust mucosal immunity. CD8<sup>+</sup> cyt..

Scholarly works icon

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies

S Jegaskanda, ER Job, M Kramski, K Laurie, G Isitman, R De Rose, WR Winnall, I Stratov, AG Brooks, PC Reading, SJ Kent

2013-02-15

A better understanding of immunity to influenza virus is needed to generate cross-protective vaccines. Engagement of Ab-dependent ..

Scholarly works icon

Comparison of influenza and SIV specific CD8 T cell responses in macaques

S Jegaskanda, JC Reece, R de Rose, J Stambas, L Sullivan, AG Brooks, SJ Kent, A Sexton

2012-03-05

Macaques are a potentially useful non-human primate model to compare memory T-cell immunity to acute virus pathogens such as influ..

University of Melbourne Researchers

Stephen Kent's Profile Picture
Stephen Kent

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224